6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Altamira Therapeutics Ltd.
Filed: January 19, 2024
Period of Report: January 19, 2024
Accession Number: 0001213900-24-004886

View Document ↗ View on SEC.gov ↗